5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.62▼ | 2.63▼ | 2.63▼ | 2.62▼ | 3.23▼ |
MA10 | 2.62▼ | 2.60▼ | 2.59▲ | 2.73▼ | 11.40▼ |
MA20 | 2.59▲ | 2.60▲ | 2.61▼ | 3.16▼ | 30.90▼ |
MA50 | 2.61▼ | 2.66▼ | 2.64▼ | 14.66▼ | 61.99▼ |
MA100 | 2.66▼ | 2.75▼ | 2.85▼ | 37.41▼ | 151.04▼ |
MA200 | 2.77▼ | 3.30▼ | 8.21▼ | 58.70▼ | 559.63▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.007▲ | 0.007▲ | 0.953▲ | -1.093▼ |
RSI | 48.993▼ | 47.979▼ | 47.207▼ | 28.111▼ | 24.253▼ |
STOCH | 35.417 | 82.114▲ | 71.114 | 21.867 | 2.035▼ |
WILL %R | -87.500▼ | -34.146 | -51.724 | -84.592▼ | -99.150▼ |
CCI | -64.671 | 35.066 | 31.818 | -46.300 | -83.224 |
Friday, February 14, 2025 06:09 AM
COPENHAGEN - Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage TechBio company with a current market capitalization of $16.36 million, has confirmed its compliance with Nasdaq's minimum ...
|
Friday, February 14, 2025 05:11 AM
2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has received confirmation from the Nasdaq ...
|
Friday, February 14, 2025 05:10 AM
Evaxion Biotech (EVAX) has received confirmation from the Nasdaq Stock Market that it has re-established compliance with Nasdaq’s minimum ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/02/25 | 2.51 | 2.6751 | 2.44 | 2.60 | 354,353 |
14/02/25 | 2.61 | 2.79 | 2.42 | 2.49 | 1,500,126 |
13/02/25 | 2.72 | 2.7991 | 2.59 | 2.61 | 183,552 |
12/02/25 | 2.67 | 2.78 | 2.62 | 2.62 | 160,580 |
11/02/25 | 2.57 | 2.90 | 2.57 | 2.78 | 468,287 |
10/02/25 | 2.41 | 2.68 | 2.30 | 2.62 | 480,624 |
07/02/25 | 2.76 | 2.83 | 2.56 | 2.58 | 501,604 |
06/02/25 | 2.86 | 2.92 | 2.75 | 2.75 | 580,556 |
05/02/25 | 2.94 | 3.25 | 2.90 | 2.99 | 1,535,133 |
04/02/25 | 3.93 | 4.05 | 2.93 | 3.27 | 62,828,962 |
|
|
||||
|
|
||||
|
|